- Home
- EBMT vs PEPG Comparison
EBMT vs PEPG Comparison
Compare EBMT & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBMT | PEPG |
|---|---|---|
| Founded | 1922 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.5M | 207.1M |
| IPO Year | 2009 | 2022 |
Fundamental Metrics
Financial Performance| Metric | EBMT | PEPG |
|---|---|---|
| Price | $22.54 | $3.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $24.00 | $11.17 |
| AVG Volume (30 Days) | 31.8K | ★ 1.0M |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | ★ 53.23 | 25.61 |
| EPS | ★ 0.98 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | $22.87 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.80 | $1.17 |
| 52 Week High | $24.66 | $7.80 |
Technical Indicators
Market Signals| Indicator | EBMT | PEPG |
|---|---|---|
| Relative Strength Index (RSI) | 37.78 | 59.32 |
| Support Level | $21.59 | $1.47 |
| Resistance Level | $22.87 | $3.14 |
| Average True Range (ATR) | 0.63 | 0.20 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 30.71 | 27.27 |
Price Performance
Historical ComparisonAbout EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.